Puerto Rico Manufacturing Proposition Analysis
Note: Company names are illustrative
Companies fall into archetypes for analysis and prioritization
Biopharma
Prioritize outreach to companies who own or
could manufacture medically essential products
Multinational companies (MNCs)
•
•
•
.
Consolidation of key products in few top
companies (branded and generics)
Prioritize companies with existing footprint
in PR given easier route to expansion
Cost sensitivity in many segments, likely to
find PR expansion attractive
Open the door to upstream conversations
(e.g., API, raw materials)
CDMOS (Contract Development and
Manufacturing Organizations)1
•
Well positioned to pool demand across
smaller companies looking for reliable
coverage of US market
Some have presence in PR already they
can leverage for expansion, and turnkey
sites improve ROIC
Small to mid-sized companies
.
•
Medtronic
abbvie
teva
stryker®
Catalent.
Thermo Fisher
SCIENTIFIC
Expected sig. growth in US sales over next 5 years
Opportunity to capture growth or transition to
commercial manufacturing for new products
Initially, address through small company
advocates and trade associations for scale
1. Inclusive of CMOs (Contract Manufacturing Organizations)
biohaven
☐ pharmaceuticals
NUVASIVE
TTT
JABIL
flex.
Medtech
Target OEMs and CDMOS with footprint in PR in
key product segments for incremental expansion,
esp. by bringing more supply chain steps to PR
Large OEMs
Top few companies have very broad
portfolios covering many key segments
Prioritize OEMs with existing footprint;
likely to have underutilized capacity that
can be leveraged for additional production,
or ability to build out on a campus / nearby
for new capabilities
Existing manufacturing ecosystem across
the value chain
Leading CDMOs or suppliers with
coverage of US Medtech ecosystem
Potential to pool demand across smaller
companies or without US mfg footprint -
can help companies establish US
•
•
•
component of supply chains
Availability of mfg ecosystem, labor, and
brownfield sites which improve ROIC make
PR appealing to these companies
Increasingly active in PPE / consumables
13
Copyright 2020 by Boston Consulting Group. All rights reserved.View entire presentation